GO
Loading...

Enter multiple symbols separated by commas

Search results for "VTUS"

REFINE RESULTS

SEARCH RESULTS

About 1 results. Sort By: Date | Relevance
UPDATE 2-GlobeImmune Hep B drug fails mid-stage study, shares plunge

May 27- Drug developer GlobeImmune Inc said its experimental hepatitis B drug did not reduce infection in patients after 24 weeks of treatment in a mid-stage study, sending the company's shares down as much as 60 percent to a record low. GlobeImmune, which is developing the drug with Gilead Sciences Inc, is among several drugmakers looking to tap the demand for...
Source: Reuters | By: Amrutha Penumudi